From left to right: Prof. Steven Le Gouill, Dr. Golriz Pahlavan, Mr. Dominique Blazy, Prof. Alain Puisieux. Partnership Institut Curie and MSDAVENIR sign a partnership to improve treatment of thymus cancer 09/21/2022
From left to right: Prof. Steven Le Gouill, Dr. Golriz Pahlavan, Mr. Dominique Blazy, Prof. Alain Puisieux.
Partnership Pediatric cancers: inclusion of the first patient in the clinical trial evaluating a promising therapy born at Institut Curie 09/05/2022
Institut Curie's Center for Cancer Immunotherapy Partnership Identification of a key enzyme for more effective and sustainable immunotherapies 07/20/2022
Proton therapy center at Institut Curie (Orsay) Partnership Institut Curie and Thales team up to create world-leading French industrial ecosystem in very high-energy electron FLASH radiotherapy 07/08/2022
Innovation Emglev Therapeutics project wins i-Lab 2022: towards Institut Curie's 29th start-up 07/05/2022
Pr Steven Le Gouill, head of Institut Curie's Hospital Complex, Delphine Aguiléra-Caron, president of Janssen France & Pr Alain Puisieux, head of Institut Curie's Research Center Partnership Institut Curie & Janssen sign a strategic framework agreement to accelerate innovation in oncology 07/04/2022
Pr Steven Le Gouill, head of Institut Curie's Hospital Complex, Delphine Aguiléra-Caron, president of Janssen France & Pr Alain Puisieux, head of Institut Curie's Research Center